Literature DB >> 2584408

Leucocyte behaviour in controlled ischaemia of the calves.

G Ciuffetti1, M Mercuri, R Lombardini, G Maragoni, L Santambrogio, E Mannarino.   

Abstract

Whole blood filterability and leucocyte behaviour (number, activation, and subfraction filterability rates) were monitored at the earliest stage of peripheral ischaemia in 18 patients with stage II peripheral occlusive arterial disease (PAOD) and 20 matched controls. A model of controlled ischaemia, using exercise to stress leg circulation, was set up and blood samples were taken before exercise, at the onset of calf pain, and at recovery from peak exercise. Leucocytes were counted, separated into their subfractions on a Ficoll-Hypaque density gradient and by adhesion to Petri dishes, and filtered in buffer (like the whole blood suspensions) through 5 microns pore diameter Nucleopore filters. Unfractionated white cells, separated under gravity, with pseudopodia or cytoplasmic irregularities were regarded as activated. The whole blood filterability rate was significantly increased at the onset of calf pain and was associated with significant increases in the number of leucocytes and in the filterability rate of the monocyte subfraction, the latter persisting throughout the recovery period. No significant changes were observed in the other variables monitored, showing that impairments in white cell rheology may be associated with ischaemia.

Entities:  

Mesh:

Year:  1989        PMID: 2584408      PMCID: PMC501868          DOI: 10.1136/jcp.42.10.1083

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Impaired filterability of white cells in acute cerebral infarction.

Authors:  G Ciuffetti; R Balendra; S E Lennie; J Anderson; G D Lowe
Journal:  BMJ       Date:  1989-04-08

2.  Age and blood cell rheology.

Authors:  G Ciuffetti; M Mercuri; M T Rizzo; S E Lennie; G D Lowe
Journal:  Gerontology       Date:  1989       Impact factor: 5.140

3.  The hemorheological role of cellular factors in peripheral vascular disease.

Authors:  G Ciuffetti; E Mannarino; L Pasqualini; M Mercuri; S E Lennie; G D Lowe
Journal:  Vasa       Date:  1988       Impact factor: 1.961

4.  Physiological variation in circulating B cell:T cell ratio in man.

Authors:  C M Steel; J Evans; M A Smith
Journal:  Nature       Date:  1974-02-08       Impact factor: 49.962

5.  Methods and theory for analysis of flow of white cell subpopulations through micropore filters.

Authors:  G B Nash; J G Jones; J Mikita; J A Dormandy
Journal:  Br J Haematol       Date:  1988-10       Impact factor: 6.998

6.  Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.

Authors:  R A Harkness; R J Lund
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

Review 7.  Leukocyte-endothelial interactions.

Authors:  J M Harlan
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

8.  Effect of total leucocyte count on whole blood filterability in patients with peripheral vascular disease.

Authors:  M J Alderman; A Ridge; A A Morley; R G Ryall; J A Walsh
Journal:  J Clin Pathol       Date:  1981-02       Impact factor: 3.411

9.  Effects of preparative procedures and of cell activation on flow of white cells through micropore filters.

Authors:  G B Nash; J G Jones; J Mikita; B Christopher; J A Dormandy
Journal:  Br J Haematol       Date:  1988-10       Impact factor: 6.998

10.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.

Authors:  R L Engler; G W Schmid-Schönbein; R S Pavelec
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

View more
  1 in total

1.  Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study.

Authors:  G Ciuffetti; M Mercuri; C Ott; R Lombardini; R Paltriccia; G Lupattelli; L Santambrogio; E Mannarino
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.